David Dodd is the Chairman, President, and CEO of GeoVax Labs, Inc., a clinical-stage biotechnology company developing vaccines and immunotherapies.
David Dodd is the Chairman, President, and CEO of GeoVax Labs, Inc., a clinical-stage biotechnology company developing vaccines and immunotherapies. He leads the company's Phase 1/2 clinical trial for Gedeptin, an oncolytic solid tumor gene-directed therapy.
Full founder directory · Investor directory · Company funding database · Fundraising library